PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA
January 30, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Jan. 30, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech to Hold Shareholder Call
January 18, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Jan. 18, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Discusses Upcoming Clinical Trial with Principal Investigator Dr. Manuel Hidalgo
January 10, 2017 09:10 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Jan. 10, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA
January 04, 2017 09:25 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
December 27, 2016 09:30 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Submits Pre-IND Meeting Package to FDA
December 15, 2016 09:46 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Dec. 15, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Discusses Upcoming Clinical Trial in Pancreatic Cancer with First Principal Investigator
December 07, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Granted FDA Pre-IND Meeting for Pancreatic Cancer Therapy
November 29, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Nov. 29, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
University of Northern Colorado Presenting PharmaCyte Biotech’s Cannabis Research at the 2017 American Chemical Society National Meeting
November 14, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Requests Pre-IND Meeting with FDA for its Pancreatic Cancer Clinical Trial
November 01, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...